C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 495/04 (2006.01) A61K 31/4188 (2006.01) C07D 487/04 (2006.01) C07D 491/04 (2006.01) C07D 495/14 (2006.01)
Patent
CA 2652238
The invention encompasses novel compounds of Formula or pharmaceutically acceptable salts thereof. These compounds are inhibitors of the microsomal prostaglandin E synthase-1 (mPGES-1) enzyme and are therefore useful to treat pain and/or inflammation from a variety of diseases or conditions, such as osteoarthritis, rheumatoid arthritis and acute or chronic pain. Methods of treating diseases or conditions mediated by the mPGES-1 enzyme and pharmacuetical compositions are also encompassed.
L'invention concerne de nouveaux composés de formule ou des sels pharmaceutiquement acceptables de ceux-ci. Ces composés sont des inhibiteurs de l'enzyme prostaglandine E synthase-1 microsomale (mPGES-1) et sont par conséquent utiles pour traiter la douleur et/ou l'inflammation créées par une diversité de maladies ou d'états, telles que l'ostéo-arthrite, la polyarthrite rhumatoïde et la douleur aiguë ou chronique. L'invention concerne également des procédés de traitement de maladies ou d'états à médiation par l'enzyme mPGES-1 et des compositions pharmaceutiques.
Cote Bernard
Ducharme Yves
Frenette Richard
Friesen Richard
Giroux Andre
Merck Frosst Canada Ltd.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Phenanthrene derivatives as mpges-1 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phenanthrene derivatives as mpges-1 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenanthrene derivatives as mpges-1 inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1908320